Circulating Cell-free DNA as a Prognostic Biomarker in Patients with Advanced ALK+ Non–small Cell Lung Cancer in the Global Phase III ALEX Trial
暂无分享,去创建一个
A. Shaw | S. Ou | T. Mok | S. Peters | R. Dziadziuszko | D. Camidge | S. Gadgeel | M. Nowicka | P. N. Morcos | W. Bordogna | J. Noé | K. Konopa | V. Smoljanović